Topiramate

Generic Name: Topiramate

Brand Names: Topamax

Topiramate is used to treat epilepsy and migraine prevention. It is available as Topamax and is commonly prescribed in the neurological category.

NeurologicalAnticonvulsantsMigraine

Drug Class

Anticonvulsant / Antiepileptic (Sulfamate-Substituted Monosaccharide)

Pregnancy

Category D; contraindicated for migraine prevention in pregnancy. Associated with increased risk of cleft lip and cleft palate (oral clefts) when used during the first trimester. Women of childbearing age should use effective contraception.

Available Forms

25 mg oral tablet, 50 mg oral tablet, 100 mg oral tablet, 200 mg oral tablet, 15 mg sprinkle capsule, 25 mg sprinkle capsule, 25 mg extended-release capsule (Qudexy XR, Trokendi XR), 50 mg extended-release capsule, 100 mg extended-release capsule, 150 mg extended-release capsule, 200 mg extended-release capsule

What It's Used For

Dosage Quick Reference

These are general dosage guidelines. Your doctor will determine the appropriate dose for your specific situation.

Condition	Starting Dose	Maintenance Dose
Epilepsy (adjunctive, adults)	25-50 mg daily, increase by 25-50 mg/week	200-400 mg daily in 2 divided doses
Migraine Prophylaxis (adults)	25 mg daily in the evening for week 1	100 mg daily in 2 divided doses (50 mg twice daily); titrate by 25 mg/week
Epilepsy (monotherapy, adults)	25 mg twice daily for week 1	400 mg daily in 2 divided doses; titrate by 50 mg/week

Side Effects

Common Side Effects:

Paresthesias
Fatigue
Cognitive dysfunction (word-finding difficulty)
Dizziness
Somnolence
Anorexia/weight loss
Nausea
Diarrhea

Serious Side Effects:

Metabolic acidosis
Kidney stones
Oligohidrosis and hyperthermia
Acute myopia/secondary angle-closure glaucoma
Mood disorders/suicidal ideation
Oral clefts in pregnancy

Drug Interactions

Oral contraceptives (ethinyl estradiol): Topiramate at doses of 200 mg/day or higher can decrease the effectiveness of combination oral contraceptives by inducing CYP3A4 metabolism of estrogen. An alternative or additional contraceptive method is recommended.
Carbonic anhydrase inhibitors (acetazolamide, zonisamide): Concurrent use increases the risk of metabolic acidosis and nephrolithiasis (kidney stones). Avoid combination when possible.
Valproic acid: Co-administration increases ammonia levels and risk of hyperammonemic encephalopathy, sometimes without elevated liver enzymes. Both drugs can also cause hypothermia when combined.
CNS depressants (alcohol, benzodiazepines, opioids): Topiramate has CNS depressant effects and can potentiate sedation, dizziness, and cognitive impairment when combined with other CNS depressants.
Lithium: Topiramate can alter lithium levels; monitor lithium serum concentrations closely when initiating or adjusting topiramate.
Metformin: Topiramate can increase metformin exposure and decrease metformin clearance. Monitor blood glucose closely in diabetic patients.

Additional Information

Topiramate is an anticonvulsant medication with multiple mechanisms of action. It is used to treat epilepsy, prevent migraine headaches, and (in combination with phentermine) for weight management.

Mechanism of Action

Topiramate works through multiple mechanisms:

Sodium channel blockade: Stabilizes neuronal membranes by blocking voltage-gated sodium channels
GABA-A receptor potentiation: Enhances GABA-mediated inhibition
Glutamate receptor antagonism: Blocks AMPA/kainate glutamate receptors
Carbonic anhydrase inhibition: Weak inhibition of CA isoenzymes II and IV
Reduces neuronal excitability: Net effect of antiexcitatory and proinhibitory actions

Available Formulations

Immediate-release tablets: 25 mg, 50 mg, 100 mg, 200 mg
Sprinkle capsules: 15 mg, 25 mg
Extended-release capsules (Trokendi XR, Qudexy XR): Various strengths

Medical Uses

FDA-Approved Indications:

Partial-onset seizures and primary generalized tonic-clonic seizures (adults and children ≥2 years)
Lennox-Gastaut syndrome (adjunctive therapy)
Migraine prophylaxis (adults and adolescents ≥12 years)

In Combination (Qsymia):

Chronic weight management (with phentermine)

Dosing Guidelines

Epilepsy (Monotherapy):

Week 1: 25 mg twice daily
Titrate by 25-50 mg/week
Target: 200 mg twice daily (adults)

Epilepsy (Adjunctive):

Start 25-50 mg/day; titrate to 200-400 mg/day divided twice daily

Migraine Prophylaxis:

Week 1: 25 mg nightly
Increase by 25 mg weekly
Target: 50 mg twice daily (100 mg/day)

Important Safety Information

Boxed Warning:

Fetal toxicity: Increased risk of oral clefts (cleft lip/palate) with first trimester exposure

Contraindications:

Recent alcohol use (within 6 hours before and after extended-release)
With metformin for weight loss in patients with metabolic acidosis

Warnings and Precautions:

Metabolic acidosis: Monitor bicarbonate levels, especially in renal disease, severe respiratory disorders, or with ketogenic diet
Cognitive dysfunction: Word-finding difficulty, memory impairment, concentration problems
Kidney stones: Increased risk; maintain adequate hydration
Oligohidrosis and hyperthermia: Especially in children; monitor during hot weather
Acute myopia and secondary angle-closure glaucoma: Usually within first month; discontinue if occurs
Mood disorders: Monitor for depression and suicidal ideation

Drug Interactions

CNS depressants: Additive CNS depression
Carbonic anhydrase inhibitors (acetazolamide, zonisamide): Increased kidney stone risk
Oral contraceptives: Reduced efficacy at doses ≥200 mg/day
Valproic acid: Increased ammonia; monitor for hyperammonemia/encephalopathy
Lithium: May increase or decrease lithium levels
Phenytoin, carbamazepine: May reduce topiramate levels

Special Populations

Hepatic Impairment: Use with caution
Renal Impairment: Reduce dose by 50% if CrCl <70 mL/min
Pregnancy: Avoid if possible; contraindicated for migraine prevention
Lactation: Present in breast milk; monitor infant
Pediatric: Approved for seizures ≥2 years; migraine ≥12 years

Frequently Asked Questions

Paresthesias (tingling, numbness, or "pins and needles") are among the most common side effects of topiramate, occurring in about 10-15% of patients. This is related to the drug's carbonic anhydrase inhibition, which affects nerve function. The tingling is usually mild and often improves with continued use or potassium supplementation.

Weight loss is a common side effect of topiramate, which is one reason it is included in the combination weight-loss medication phentermine/topiramate (Qsymia). The appetite-suppressing mechanism is not fully understood but may involve effects on appetite-regulating neurotransmitters. Not everyone loses weight, but it is more common than weight gain.

Topiramate can alter the taste of carbonated beverages, making them taste flat or metallic. This is harmless but can be bothersome. It is related to the drug's carbonic anhydrase inhibition, which affects carbon dioxide metabolism.

Some patients experience word-finding difficulty, slowed thinking, difficulty concentrating, or memory problems, sometimes referred to as "brain fog." These effects are dose-related and more common at higher doses. Slow dose titration helps minimize cognitive side effects. Inform your doctor if these symptoms interfere with daily activities.

Very important. Topiramate increases the risk of kidney stones, especially in patients who do not drink enough fluids. Aim for at least 6 to 8 glasses of water daily. Avoiding a high-protein, low-carbohydrate (ketogenic) diet can also help reduce kidney stone risk.

Questions to Ask Your Doctor

Consider discussing these topics at your next appointment:

✓Should my bicarbonate levels be monitored for metabolic acidosis while on topiramate?
✓Do I need to use a backup contraceptive method since topiramate can reduce the effectiveness of birth control pills?
✓What is the target dose for my condition, and how slowly should the dose be increased?
✓Should I have my eyes checked for acute angle-closure glaucoma, a rare but serious side effect?
✓What cognitive side effects should I watch for, and when should I report them?

Schedule an Appointment

Related Health Conditions

This medication is commonly used to treat or manage the following conditions:

Attention Deficit Hyperactivity Disorder (ADHD)

ADHD is a neurodevelopmental disorder marked by inattention, hyperactivity, and/or impulsivity, stemming from complex interactions between genetics, brain differences, and environmental factors, not poor parenting.

Learn More

Lupus Anticoagulant

Lupus anticoagulant is an antibody causing paradoxical prolonged clotting tests yet increasing thrombosis risk, linked to antiphospholipid syndrome and autoimmune diseases, despite not always requiring lupus diagnosis.

Learn More

Migraine

Migraine is a debilitating neurological condition causing recurrent headaches with throbbing pain, nausea, and light/sound sensitivity, likely stemming from complex brain, nerve, and blood vessel interactions.

Learn More

Seizures

Seizures are sudden brain disturbances caused by abnormal electrical activity, manifesting in various symptoms and linked to conditions like epilepsy, injury, infection, or imbalances.

Learn More

Vertigo

Vertigo, a spinning sensation distinct from dizziness, often stems from inner ear or brain issues like BPPV or Meniere's, sometimes triggered by head trauma or medication.

Learn More

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.